The essentials
Mangione's state murder trial begins September 2026; federal charges proceed separately in October 2026.
Luigi Mangione is charged with murdering UnitedHealthcare CEO Brian Thompson in a December 2024 shooting in Midtown Manhattan. His New York state murder trial is scheduled to begin in September, while separate federal charges are also pending against him.
Mangione has pleaded not guilty to all charges. Evidence recovered includes a 3D-printed pistol and a notebook from his arrest in Pennsylvania. A judge dismissed a gun magazine charge, though other charges remain intact.
The case involves both state and federal proceedings, with the federal trial set for October 13, 2026, following the state trial. Mangione's legal defense includes a psychiatric component, with materials requested to be sealed to protect the federal proceedings.
Other ways to read this story.
Alternative framings generated by SigNews. These are not independent sources or attributed quotations.
State trial precedes federal proceedings by five weeks
The September 8 state trial start gives way to a October 13 federal trial, creating a compressed legal schedule spanning two jurisdictions. This sequential structure allows the state case to proceed first, with federal charges following shortly after. The timeline reflects the complexity of prosecuting charges across both legal systems.
Defendant faces parallel prosecution in state and federal courts
Mangione confronts charges in both New York state and federal courts simultaneously, doubling the legal exposure. Each jurisdiction maintains separate proceedings with distinct charges. A judge's dismissal of a gun magazine charge in state court shows potential variance in charge viability across jurisdictions as the case progresses.